Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?
about
Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseThe effect of gender, age, and symptom severity in late-life depression on the risk of all-cause mortality: the Bambuí Cohort Study of Aging.Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.Bi-phasic regulation of glycogen content in astrocytes via Cav-1/PTEN/PI3K/AKT/GSK-3β pathway by fluoxetine.The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies.Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study.Commentary on: predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment?The association between insulin resistance, metabolic variables, and depressive symptoms in Mexican-American elderly: A population-based study.Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.Genetic Overlap Between Depression and Cardiometabolic DisordersBiomarkers in Mood Disorders Among the Elderly: Can They Contribute to Diagnosis and Prognosis?
P2860
Q27027319-4E45477B-1B3B-4750-B4F1-145FAAE2EB94Q33774315-5D4CB337-F34F-4145-AB9A-BB1D9C184073Q34442861-D26D2063-93D5-40CD-BB84-B57234CB2886Q35828096-E6B20497-0EAB-454F-973F-180902F68C86Q38944925-D06AF3C5-18EB-46CF-9A90-D631C6110168Q39100917-AD93EC92-0298-4787-A56C-EFF26486064CQ39668647-FA7B2C1F-7D4A-4110-AB12-FE225D688544Q43515598-C469E0D2-9762-4968-8F66-325A5C6D5387Q44591494-1B5163FF-A2A8-49BC-8D82-A6B24736C91AQ47765365-D64FA6CD-07DD-4CF7-8585-AF1782F24BE4Q50588053-4066D374-1648-49E9-A359-336A95E7966AQ57077043-8AEADC8E-1AEE-446B-BA2F-E1889FAAD55DQ57812968-6FBE27A3-163B-4913-B4FB-5B026F7C13B5
P2860
Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@en
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@nl
type
label
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@en
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@nl
prefLabel
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@en
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@nl
P2093
P2860
P1476
Platelet GSK3B activity in pat ...... rity and cognitive impairment?
@en
P2093
Helena Passarelli Giroud Joaquim
Leda Leme Talib
Orestes Vicente Forlenza
Vanessa Rodrigues Jesus de Paula
Wagner Farid Gattaz
P2860
P304
P356
10.3109/15622975.2010.551408
P577
2011-02-11T00:00:00Z